Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Molecular Pharmacology|March 19, 2017
Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes <i>β</i>-Arrestin 2 RecruitmentNadine Dupuis, Céline Laschet, Delphine Franssen, et al.
Prostaglandins & Other Lipid Mediators|March 7, 2006
Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusionPhilippe Kolh, Stéphanie Rolin, Vincent Tchana-Sato, et al.
Experimental Physiology|October 14, 2006
Cardiovascular haemodynamics and ventriculo-arterial coupling in an acute pig model of coronary ischaemia-reperfusionLieve Lanoye, Patrick Segers, Vincent Tchana-Sato, et al.
Frontiers in Endocrinology|March 14, 2024
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantismManuela Caruso, Diego Mazzatenta, Sofia Asioli, et al.
Prostaglandins & Other Lipid Mediators|March 15, 2011
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthaseCéline Cherdon, Stéphanie Rolin, Julien Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004
Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding timeJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Thrombosis Research|August 27, 2005
Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pigJean-Michel Dogné, Stéphanie Rolin, Michel Pétein, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2005
In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonistJulien Hanson, Stephanie Rolin, Denis Reynaud, et al.
Journal of Medicinal Chemistry|June 9, 2006
Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptorJulien Hanson, Denis Reynaud, Na Qiao, et al.
Journal of Medicinal Chemistry|December 20, 2017
7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar PotencyEric Goffin, Thomas Drapier, Anja Probst Larsen, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Molecular Pharmacology|March 19, 2017
Activation of the Orphan G Protein-Coupled Receptor GPR27 by Surrogate Ligands Promotes <i>β</i>-Arrestin 2 RecruitmentNadine Dupuis, Céline Laschet, Delphine Franssen, et al.
Prostaglandins & Other Lipid Mediators|March 7, 2006
Evaluation of BM-573, a novel TXA2 synthase inhibitor and receptor antagonist, in a porcine model of myocardial ischemia-reperfusionPhilippe Kolh, Stéphanie Rolin, Vincent Tchana-Sato, et al.
Experimental Physiology|October 14, 2006
Cardiovascular haemodynamics and ventriculo-arterial coupling in an acute pig model of coronary ischaemia-reperfusionLieve Lanoye, Patrick Segers, Vincent Tchana-Sato, et al.
Frontiers in Endocrinology|March 14, 2024
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantismManuela Caruso, Diego Mazzatenta, Sofia Asioli, et al.
Prostaglandins & Other Lipid Mediators|March 15, 2011
BM-573 inhibits the development of early atherosclerotic lesions in Apo E deficient mice by blocking TP receptors and thromboxane synthaseCéline Cherdon, Stéphanie Rolin, Julien Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 27, 2004
Pharmacological characterization of N-tert-butyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding timeJean-Michel Dogné, Julien Hanson, Xavier de Leval, et al.
Thrombosis Research|August 27, 2005
Characterization of an original model of myocardial infarction provoked by coronary artery thrombosis induced by ferric chloride in pigJean-Michel Dogné, Stéphanie Rolin, Michel Pétein, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 2005
In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl]urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonistJulien Hanson, Stephanie Rolin, Denis Reynaud, et al.
Journal of Medicinal Chemistry|June 9, 2006
Synthesis and pharmacological evaluation of novel nitrobenzenic thromboxane modulators as antiplatelet agents acting on both the alpha and beta isoforms of the human thromboxane receptorJulien Hanson, Denis Reynaud, Na Qiao, et al.
Journal of Medicinal Chemistry|December 20, 2017
7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar PotencyEric Goffin, Thomas Drapier, Anja Probst Larsen, et al.
Pageof 7